Publications by authors named "Handing Xie"

Background: Multiple system atrophy (MSA) is a progressive neurodegenerative disorder with diverse symptoms that complicate diagnosis. We aimed to characterize MSA-related symptoms, medications, and healthcare resource utilization (HCRU).

Research Design And Methods: This retrospective cohort study used a large US claims database.

View Article and Find Full Text PDF

Rationale: There is a lack of real-world characterization of healthcare costs and associated cost drivers in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease (PH-COPD).

Objectives: To examine (1) excess healthcare resource utilization (HCRU) and associated costs in patients with PH-COPD compared to COPD patients without PH; and (2) patient characteristics that are associated with higher healthcare costs in patients with PH-COPD.

Methods: This study analyzed data from the IQVIA PharMetrics Plus database (OCT2014-MAY2020).

View Article and Find Full Text PDF
Article Synopsis
  • - This study aimed to estimate the prevalence and cumulative incidence of multiple system atrophy (MSA) in the US, addressing gaps in existing literature that relied on older data.
  • - Researchers analyzed a claims database from 2016 to 2021, finding a crude prevalence of 7.2 per 100,000 people in 2021, which adjusted to 12.4 per 100,000 when considering population age.
  • - The research highlighted the importance of understanding MSA's real-world impact on healthcare needs, with cumulative incidence rates showing more cases than previously recognized.
View Article and Find Full Text PDF

Introduction: Clinical practice guidelines recommend initiating a high-intensity LLT and continued monitoring of low-density lipoprotein cholesterol (LDL-C) following acute coronary syndrome (ACS). We used real-world data to describe LLT utilization after discharge and 1-year adherence. The reduction in LDL-C was also evaluated.

View Article and Find Full Text PDF